Robert McDowell
2014
In 2014, Robert McDowell earned a total compensation of $357.4K as Senior Vice President of Drug Discovery at MyoKardia.
Compensation breakdown
| Non-Equity Incentive Plan | $61,418 |
|---|---|
| Option Awards | $10,078 |
| Salary | $285,375 |
| Other | $500 |
| Total | $357,371 |
McDowell received $285.4K in salary, accounting for 80% of the total pay in 2014.
McDowell also received $61.4K in non-equity incentive plan, $10.1K in option awards and $500 in other compensation.
Rankings
In 2014, Robert McDowell's compensation ranked 11,302nd out of 13,032 executives tracked by ExecPay. In other words, McDowell earned more than 13.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,302 out of 13,032 | 13th |
Division Manufacturing | 4,327 out of 4,966 | 13th |
Major group Chemicals And Allied Products | 1,492 out of 1,686 | 12th |
Industry group Drugs | 1,205 out of 1,365 | 12th |
Industry Pharmaceutical Preparations | 925 out of 1,043 | 11th |
Source: SEC filing on April 28, 2016.
McDowell's colleagues
We found one more compensation record of an executive who worked with Robert McDowell at MyoKardia in 2014.
2014
Tassos Gianakakos
MyoKardia